Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes
出版年份 2019 全文链接
标题
Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes
作者
关键词
-
出版物
Scientific Reports
Volume 9, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-22
DOI
10.1038/s41598-019-52224-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of serum levels with bone content and gene expression indicate a contradictory effect of kidney transplantation on sclerostin
- (2019) Maria Júlia Correia Lima Nepomuceno Araújo et al. KIDNEY INTERNATIONAL
- Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
- (2018) Henrik Boltenstål et al. CALCIFIED TISSUE INTERNATIONAL
- High glucose alters the secretome of mechanically stimulated osteocyte-like cells affecting osteoclast precursor recruitment and differentiation
- (2017) Marta Maycas et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Osteocytic signalling pathways as therapeutic targets for bone fragility
- (2016) Lilian I. Plotkin et al. Nature Reviews Endocrinology
- Mechanisms of diabetes mellitus-induced bone fragility
- (2016) Nicola Napoli et al. Nature Reviews Endocrinology
- Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells
- (2015) Ken-ichiro Tanaka et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Osteocytic Sclerostin Expression in Alveolar Bone in Rats With Diabetes Mellitus and Ligature-Induced Periodontitis
- (2015) Ji-Hye Kim et al. JOURNAL OF PERIODONTOLOGY
- Biological Regulation of Bone Quality
- (2014) Tamara Alliston Current Osteoporosis Reports
- The expanding role of Wnt signaling in bone metabolism
- (2013) Alexander G. Robling BONE
- The Osteocyte: An Endocrine Cell … and More
- (2013) Sarah L. Dallas et al. ENDOCRINE REVIEWS
- Osteoporosis—Bone Remodeling and Animal Models
- (2013) Ermanno Bonucci et al. TOXICOLOGIC PATHOLOGY
- Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus
- (2012) Agostino Gaudio et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
- (2012) Luigi Gennari et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Keratocan is Expressed by Osteoblasts and Can Modulate Osteogenic Differentiation
- (2011) John C. Igwe et al. CONNECTIVE TISSUE RESEARCH
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
- (2011) David R. Whiting et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo
- (2011) Stacey M Woo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism
- (2011) Gerald J Atkins et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
- (2011) Antonia García-Martín et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Matrix-embedded cells control osteoclast formation
- (2011) Jinhu Xiong et al. NATURE MEDICINE
- Evidence for osteocyte regulation of bone homeostasis through RANKL expression
- (2011) Tomoki Nakashima et al. NATURE MEDICINE
- Streptozotocin, Type I Diabetes Severity and Bone
- (2009) Katherine Motyl et al. BIOLOGICAL PROCEDURES ONLINE
- Osteocytes, mechanosensing and Wnt signaling
- (2008) Lynda F. Bonewald et al. BONE
- Establishment of an Osteocyte-like Cell Line, MLO-Y4
- (2006) Yoichi Kato et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started